Example of Advances in Virology format
Recent searches

Example of Advances in Virology format Example of Advances in Virology format Example of Advances in Virology format Example of Advances in Virology format Example of Advances in Virology format Example of Advances in Virology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Advances in Virology format Example of Advances in Virology format Example of Advances in Virology format Example of Advances in Virology format Example of Advances in Virology format Example of Advances in Virology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Advances in Virology — Template for authors

Publisher: Hindawi
Categories Rank Trend in last 3 yrs
Infectious Diseases #121 of 288 up up by 5 ranks
Virology #43 of 69 down down by 1 rank
journal-quality-icon Journal quality:
Good
calendar-icon Last 4 years overview: 30 Published Papers | 112 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 23/07/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

Springer

Quality:  
High
CiteRatio: 6.0
SJR: 2.135
SNIP: 1.267
open access Open Access

Springer

Quality:  
High
CiteRatio: 6.0
SJR: 1.026
SNIP: 1.34
open access Open Access

Elsevier

Quality:  
High
CiteRatio: 5.9
SJR: 1.175
SNIP: 1.033
open access Open Access
recommended Recommended

Elsevier

Quality:  
High
CiteRatio: 23.9
SJR: 4.491
SNIP: 3.727

Journal Performance & Insights

CiteRatio

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

A measure of average citations received per peer-reviewed paper published in the journal.

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

3.7

10% from 2019

CiteRatio for Advances in Virology from 2016 - 2020
Year Value
2020 3.7
2019 4.1
2018 3.7
2017 3.1
2016 2.9
graph view Graph view
table view Table view

0.956

36% from 2019

SJR for Advances in Virology from 2016 - 2020
Year Value
2020 0.956
2019 0.701
2018 0.732
2017 0.838
2016 0.49
graph view Graph view
table view Table view

1.333

72% from 2019

SNIP for Advances in Virology from 2016 - 2020
Year Value
2020 1.333
2019 0.777
2018 1.069
2017 0.78
2016 0.353
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has decreased by 10% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

insights Insights

  • SJR of this journal has increased by 36% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 72% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Advances in Virology

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Hindawi

Advances in Virology

Advances in Virology is a peer-reviewed, open access journal that publishes original research articles as well as review articles in all areas of virology.... Read More

Infectious Diseases

Virology

Medicine

i
Last updated on
22 Jul 2020
i
ISSN
1687-8639
i
Impact Factor
Low - 0.485
i
Acceptance Rate
29%
i
Frequency
Not provided
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Green faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
unsrt
i
Citation Type
Numbered
[25]
i
Bibliography Example
C. W. J. Beenakker. “Specular andreev reflection in graphene”. Phys. Rev. Lett., vol. 97, no. 6, 067007, 2006.

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.1155/2011/734690
The Effects of Temperature and Relative Humidity on the Viability of the SARS Coronavirus
Kwok-Hung Chan1, J. S. Malik Peiris1, Siu Yan Lam1, Leo L.M. Poon1, Kwok-Yung Yuen1, Wing-Hong Seto1
01 Oct 2011 - Advances in Virology

Abstract:

The main route of transmission of SARS CoV infection is presumed to be respiratory droplets. However the virus is also detectable in other body fluids and excreta. The stability of the virus at different temperatures and relative humidity on smooth surfaces were studied. The dried virus on smooth surfaces retained its viabili... The main route of transmission of SARS CoV infection is presumed to be respiratory droplets. However the virus is also detectable in other body fluids and excreta. The stability of the virus at different temperatures and relative humidity on smooth surfaces were studied. The dried virus on smooth surfaces retained its viability for over 5 days at temperatures of 22–25°C and relative humidity of 40–50%, that is, typical air-conditioned environments. However, virus viability was rapidly lost (>3 log10) at higher temperatures and higher relative humidity (e.g., 38°C, and relative humidity of >95%). The better stability of SARS coronavirus at low temperature and low humidity environment may facilitate its transmission in community in subtropical area (such as Hong Kong) during the spring and in air-conditioned environments. It may also explain why some Asian countries in tropical area (such as Malaysia, Indonesia or Thailand) with high temperature and high relative humidity environment did not have major community outbreaks of SARS. read more read less

Topics:

Relative humidity (60%)60% related to the paper, Humidity (51%)51% related to the paper
View PDF
802 Citations
open accessOpen access Journal Article DOI: 10.1155/2012/805629
Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles
Mark S. Ferguson1, Nicholas R. Lemoine1, Nicholas R. Lemoine2, Yaohe Wang2, Yaohe Wang1
31 Jan 2012 - Advances in Virology

Abstract:

Despite recent advances in both surgery and chemoradiotherapy, mortality rates for advanced cancer remain high. There is a pressing need for novel therapeutic strategies; one option is systemic oncolytic viral therapy. Intravenous administration affords the opportunity to treat both the primary tumour and any metastatic depos... Despite recent advances in both surgery and chemoradiotherapy, mortality rates for advanced cancer remain high. There is a pressing need for novel therapeutic strategies; one option is systemic oncolytic viral therapy. Intravenous administration affords the opportunity to treat both the primary tumour and any metastatic deposits simultaneously. Data from clinical trials have shown that oncolytic viruses can be systemically delivered safely with limited toxicity but the results are equivocal in terms of efficacy, particularly when delivered with adjuvant chemotherapy. A key reason for this is the rapid clearance of the viruses from the circulation before they reach their targets. This phenomenon is mainly mediated through neutralising antibodies, complement activation, antiviral cytokines, and tissue-resident macrophages, as well as nonspecific uptake by other tissues such as the lung, liver and spleen, and suboptimal viral escape from the vascular compartment. A range of methods have been reported in the literature, which are designed to overcome these hurdles in preclinical models. In this paper, the potential advantages of, and obstacles to, successful systemic delivery of oncolytic viruses are discussed. The next stage of development will be the commencement of clinical trials combining these novel approaches for overcoming the barriers with systemically delivered oncolytic viruses. read more read less

Topics:

Virotherapy (62%)62% related to the paper, Oncolytic virus (57%)57% related to the paper
View PDF
187 Citations
open accessOpen access Journal Article DOI: 10.1155/2011/193860
Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation
Fengchun Ye1, Xiufen Lei1, Shou-Jiang Gao1
09 May 2011 - Advances in Virology

Abstract:

The life cycle of Kaposi's sarcoma-associated herpesvirus (KSHV) consists of latent and lytic replication phases. During latent infection, only a limited number of KSHV genes are expressed. However, this phase of replication is essential for persistent infection, evasion of host immune response, and induction of KSHV-related ... The life cycle of Kaposi's sarcoma-associated herpesvirus (KSHV) consists of latent and lytic replication phases. During latent infection, only a limited number of KSHV genes are expressed. However, this phase of replication is essential for persistent infection, evasion of host immune response, and induction of KSHV-related malignancies. KSHV reactivation from latency produces a wide range of viral products and infectious virions. The resulting de novo infection and viral lytic products modulate diverse cellular pathways and stromal microenvironment, which promote the development of Kaposi's sarcoma (KS). The mechanisms controlling KSHV latency and reactivation are complex, involving both viral and host factors, and are modulated by diverse environmental factors. Here, we review the cellular and molecular basis of KSHV latency and reactivation with a focus on the most recent advancements in the field. read more read less

Topics:

Kaposi's sarcoma-associated herpesvirus (61%)61% related to the paper, Lytic cycle (54%)54% related to the paper
View PDF
153 Citations
open accessOpen access Journal Article DOI: 10.1155/2013/469538
Virus Entry by Endocytosis
Anthony V. Nicola1, Hector C. Aguilar2, Jason Mercer2, Brent Ryckman, Christopher M. Wiethoff
21 Apr 2013 - Advances in Virology

Abstract:

Although viruses are simple in structure and composition, their interactions with host cells are complex. Merely to gain entry, animal viruses make use of a repertoire of cellular processes that involve hundreds of cellular proteins. Although some viruses have the capacity to penetrate into the cytosol directly through the pl... Although viruses are simple in structure and composition, their interactions with host cells are complex. Merely to gain entry, animal viruses make use of a repertoire of cellular processes that involve hundreds of cellular proteins. Although some viruses have the capacity to penetrate into the cytosol directly through the plasma membrane, most depend on endocytic uptake, vesicular transport through the cytoplasm, and delivery to endosomes and other intracellular organelles. The internalization may involve clathrin-mediated endocytosis (CME), macropinocytosis, caveolar/lipid raft-mediated endocytosis, or a variety of other still poorly characterized mechanisms. This review focuses on the cell biology of virus entry and the different strategies and endocytic mechanisms used by animal viruses. read more read less

Topics:

Receptor-mediated endocytosis (64%)64% related to the paper, Endocytic cycle (63%)63% related to the paper, Endocytosis (60%)60% related to the paper, Endosome (58%)58% related to the paper, Pinocytosis (56%)56% related to the paper
View PDF
149 Citations
open accessOpen access Journal Article DOI: 10.1155/2015/184241
Antiviral Activity of Resveratrol against Human and Animal Viruses
Yusuf Abba1, Hasliza Abu Hassim1, Hazilawati Hamzah1, Mohamed Mustapha Noordin1
29 Nov 2015 - Advances in Virology

Abstract:

Resveratrol is a potent polyphenolic compound that is being extensively studied in the amelioration of viral infections both in vitro and in vivo. Its antioxidant effect is mainly elicited through inhibition of important gene pathways like the NF-κβ pathway, while its antiviral effects are associated with inhibitions of viral... Resveratrol is a potent polyphenolic compound that is being extensively studied in the amelioration of viral infections both in vitro and in vivo. Its antioxidant effect is mainly elicited through inhibition of important gene pathways like the NF-κβ pathway, while its antiviral effects are associated with inhibitions of viral replication, protein synthesis, gene expression, and nucleic acid synthesis. Although the beneficial roles of resveratrol in several viral diseases have been well documented, a few adverse effects have been reported as well. This review highlights the antiviral mechanisms of resveratrol in human and animal viral infections and how some of these effects are associated with the antioxidant properties of the compound. read more read less

Topics:

Resveratrol (59%)59% related to the paper, Viral replication (52%)52% related to the paper
View PDF
126 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Advances in Virology.

It automatically formats your research paper to Hindawi formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Advances in Virology format uses unsrt citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Advances in Virology in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Advances in Virology guidelines and auto format it.

2. Do you follow the Advances in Virology guidelines?

Yes, the template is compliant with the Advances in Virology guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Advances in Virology?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Advances in Virology citation style.

4. Can I use the Advances in Virology templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Advances in Virology.

5. Can I use a manuscript in Advances in Virology that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Advances in Virology that you can download at the end.

6. How long does it usually take you to format my papers in Advances in Virology?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Advances in Virology.

7. Where can I find the template for the Advances in Virology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Advances in Virology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Advances in Virology's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Advances in Virology an online tool or is there a desktop version?

SciSpace's Advances in Virology is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Advances in Virology?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Advances in Virology?”

11. What is the output that I would get after using Advances in Virology?

After writing your paper autoformatting in Advances in Virology, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Advances in Virology's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Advances in Virology?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Advances in Virology. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Advances in Virology?

The 5 most common citation types in order of usage for Advances in Virology are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Advances in Virology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Advances in Virology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Advances in Virology in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Advances in Virology Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Advances in Virology formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template